COVID-19 Self-Testing Kit Market Overview:

covid-19 self-testing kit market Size, Share, Development, and Outlook Report By Availability (Over the Counter, and Prescription Based, By Testing Technology (Molecular/PCR/RNA Test, Antigen Test, and Antibody Test), By Sample Type (Nasopharyngeal & Throat Swab, and Blood Test), By Collection Kit (Nasal or Cheek Swab Test, and Saliva Test), By Application (Drugstores, Supermarkets, and Convenience Stores, Online Shopping, Medical Institutions), and By Region – Global and Regional Industry Overview, and Forecasts 2023 – 2030

• The COVID-19 pandemic led to the emergence and development of nucleic acid amplification tests (NAAT) and RT-PCR tests to detect the presence of viral genetic material in patient samples
• In 2021, APAC is the largest regional player in COVID-19 testing, accounting for 69% of the market by value
• Globally, the PCR testing market for COVID-19 is dominated by Roche and Abbott

Get the sample pages of the COVID-19 Self-Testing Kit Market report @

The COVID-19 pandemic is driving global demand for diagnostic tests

According to the database, the APAC region leads the market for COVID-19 testing, accounting for 69% of the total market by value. In North America, the US recorded a significant market size in 2021, while in Europe, South Central America, and the MEA region, the country's leading market size in 2021 were the UK, Brazil, and Israel, respectively.

Severe acute respiratory syndrome coronavirus, SARS-CoV-2, is a new coronavirus that has spread around the world, prompting the World Health Organization (WHO) to declare it a pandemic. To detect the virus, nucleic acid amplification tests (NAAT) and RT-PCR tests are used to detect the presence of viral genetic material in patient samples. NAAT was the test of choice in the early stages of the pandemic, but RT-PCR tests are now widely used due to their flexible cost, simplicity, and other properties.

Big companies dominate the COVID-19 IVD testing market

Roche, Abbott, Hologic, Becton Dickinson & Co., DiaSorin, and bioMerieux dominate the COVID-19 testing market with over 50% value share.

Ask here for more customization study @

Both Roche and Abbott dominate the COVID-19 PCR testing market due to strong sales of NAAT for COVID-19 across all regions. The NAAT market is dominated by Roche, followed by Hologic. In contrast, the multiplex NAAT market is dominated by bioMerieux, which accounts for more than 90% of the market. These big players manufacturing COVID-19 test kits may want to focus their product reach and marketing efforts on countries and spend more on R&D on diagnostic techniques for COVID-19, which could contribute to more accurate and time-consuming diagnostic tests. less.

Increased uncertainty in the COVID-19 testing market amid a new spike in COVID-19 cases along with an increase in vaccinations

COVID-19 has fueled the growth, progress, and widespread use of COVID-19 detection technology. According to research, the market size of RT-PCR is increasing with increasing public awareness, vaccine coverage, deployment of booster doses, ongoing clinical trials, and a shift to rapid antigen detection (RADT) and point-of-care (POC) tests. ) year of testing is expected to decline.

Buy this Premium Research Report @

MENAFN19012023004660010643ID1105452019